{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ATP", "K+ efflux", "NF-\u0138B", "NLRP3 inflammasome", "chalcone", "structure-activity relationship"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "33339319", "DateCompleted": {"Year": "2021", "Month": "09", "Day": "02"}, "DateRevised": {"Year": "2021", "Month": "09", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "12", "Day": "16"}], "Language": ["eng"], "ELocationID": ["5960", "10.3390/molecules25245960"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "25", "Issue": "24", "PubDate": {"Year": "2020", "Month": "Dec", "Day": "16"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Chalcones Display Anti-NLRP3 Inflammasome Activity in Macrophages through Inhibition of Both Priming and Activation Steps-Structure-Activity-Relationship and Mechanism Studies.", "Abstract": {"AbstractText": ["Chalcones are responsible for biological activity throughout fruits, vegetables, and medicinal plants in preventing and treating a variety of inflammation-related diseases. However, their structure-activity relationship (SAR) in inhibiting inflammasome activation has not been explored. We synthesized numerous chalcones and determined their SAR on lipopolysaccharide (LPS)-primed ATP-induced NLRP3 inflammasome activation. 11Cha1 displayed good inhibitory activity on release reaction of caspase-1, IL-1\u03b2, and IL-18. It significantly inhibited LPS-induced phosphorylation and proteolytic degradation of I\u0138B-\u03b1 and nuclear translocation of NF-\u0138B, but had little effect on mitogen-activated protein kinases (MAPKs) activities. Furthermore, 11Cha1 blocked LPS-induced up-regulation of NLRP3, pro-caspase-1, ASC, IL-18, and IL-1\u03b2, indicating the suppression on priming step of inflammasome activation. ASC dimerization and oligomerization are considered to be direct evidence for inflammasome activation. 11Cha1 profoundly inhibited ATP-induced formation of ASC dimers, trimers, and oligomers, and the assembly of ASC, pro-caspase-1, and NLRP3 in inflammasome formation. Decrease of intracellular K<sup>+</sup> levels is the common cellular activity elicited by all NLRP3 inflammasome activators. 11Cha1 substantially diminished ATP-mediated K<sup>+</sup> efflux, confirming the anti-NLRP3 inflammasome activity of 11Cha1. In summary, the SAR of chalcone derivatives in anti-inflammasome activities was examined. Besides, 11Cha1 inhibited both priming and activation steps of NLRP3 inflammasome activation. It inhibited NF-\u0138B activation and subsequently suppressed the up-regulation of NLRP3 inflammasome components including NLRP3, ASC, pro-caspase-1, pro-IL-18, and pro-IL-1\u03b2. Next, 11Cha1 blocked ATP-mediated K<sup>+</sup> efflux and suppressed the assembly and activation of NLRP3 inflammasome, leading to the inhibition of caspase-1 activation and proteolytic cleavage, maturation, and secretion of IL-1\u03b2 and IL-18."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, College of Medicine, National Taiwan University, No. 33, Linsen S. Rd, Taipei 100, Taiwan."}], "LastName": "Leu", "ForeName": "Wohn-Jenn", "Initials": "WJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Graduate Institute of Pharmacognosy, Taipei Medical University, No. 250, Wuxing St., Taipei 110, Taiwan."}], "LastName": "Chu", "ForeName": "Jung-Chun", "Initials": "JC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, College of Medicine, National Taiwan University, No. 33, Linsen S. Rd, Taipei 100, Taiwan."}, {"Identifier": [], "Affiliation": "Department of Pharmacy, New Taipei Municipal TuCheng Hospital, Chang Gung Memorial Hospital, New Taipei City 236, Taiwan."}], "LastName": "Hsu", "ForeName": "Jui-Ling", "Initials": "JL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, College of Medicine, National Taiwan University, No. 33, Linsen S. Rd, Taipei 100, Taiwan."}], "LastName": "Du", "ForeName": "Chi-Min", "Initials": "CM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, College of Medicine, National Taiwan University, No. 33, Linsen S. Rd, Taipei 100, Taiwan."}], "LastName": "Jiang", "ForeName": "Yi-Huei", "Initials": "YH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, College of Medicine, National Taiwan University, No. 33, Linsen S. Rd, Taipei 100, Taiwan."}], "LastName": "Hsu", "ForeName": "Lih-Ching", "Initials": "LC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Graduate Institute of Pharmacognosy, Taipei Medical University, No. 250, Wuxing St., Taipei 110, Taiwan."}], "LastName": "Huang", "ForeName": "Wei-Jan", "Initials": "WJ"}, {"Identifier": ["0000-0002-6738-6054"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, College of Medicine, National Taiwan University, No. 33, Linsen S. Rd, Taipei 100, Taiwan."}], "LastName": "Guh", "ForeName": "Jih-Hwa", "Initials": "JH"}], "GrantList": [{"GrantID": "MOST 107-2320-B-002-018-MY3 and MOST 106-2320-B-002 -005 -MY3", "Agency": "Ministry of Science and Technology, Taiwan", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Chalcones"}, {"RegistryNumber": "0", "NameOfSubstance": "Inflammasomes"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-1beta"}, {"RegistryNumber": "0", "NameOfSubstance": "Lipopolysaccharides"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "0", "NameOfSubstance": "NLR Family, Pyrin Domain-Containing 3 Protein"}, {"RegistryNumber": "139874-52-5", "NameOfSubstance": "NF-KappaB Inhibitor alpha"}, {"RegistryNumber": "8L70Q75FXE", "NameOfSubstance": "Adenosine Triphosphate"}, {"RegistryNumber": "EC 3.4.22.36", "NameOfSubstance": "Caspase 1"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Adenosine Triphosphate"}, {"QualifierName": ["metabolism"], "DescriptorName": "Caspase 1"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Chalcones"}, {"QualifierName": [], "DescriptorName": "Dimerization"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Inflammasomes"}, {"QualifierName": ["metabolism"], "DescriptorName": "Interleukin-1beta"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Lipopolysaccharides"}, {"QualifierName": ["cytology", "drug effects", "metabolism"], "DescriptorName": "Macrophages"}, {"QualifierName": ["metabolism"], "DescriptorName": "NF-KappaB Inhibitor alpha"}, {"QualifierName": ["metabolism"], "DescriptorName": "NF-kappa B"}, {"QualifierName": ["metabolism"], "DescriptorName": "NLR Family, Pyrin Domain-Containing 3 Protein"}, {"QualifierName": ["drug effects"], "DescriptorName": "Phosphorylation"}, {"QualifierName": ["drug effects"], "DescriptorName": "Pyroptosis"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Panche A.N., Diwan A.D., Chandra S.R. Flavonoids: An overview. J. Nutr. Sci. 2016;5:e47. doi: 10.1017/jns.2016.41.", "ArticleIdList": ["10.1017/jns.2016.41", "PMC5465813", "28620474"]}, {"Citation": "Mateeva N., Gangapuram M., Mazzio E., Eyunni S., Soliman K.F., Redda K.K. Biological evaluation of synthetic chalcone and flavone derivatives as anti-inflammatory agents. Med. Chem. Res. 2015;24:1672\u20131680. doi: 10.1007/s00044-014-1214-7.", "ArticleIdList": ["10.1007/s00044-014-1214-7", "PMC4390068", "25866456"]}, {"Citation": "Abd E.L., Maksoud A.I., Taher R.F., Gaara A.H., Abdelrazik E., Keshk O.S., Elawdan K.A., Morsy S.E., Salah A., Khalil H. Selective Regulation of B-Raf Dependent K-Ras/Mitogen-Activated Protein by Natural Occurring Multi-kinase Inhibitors in Cancer Cells. Front. Oncol. 2019;9:1220.", "ArticleIdList": ["PMC6861212", "31781509"]}, {"Citation": "Xiao N., Qu J., He S., Huang P., Qiao Y., Li G., Pan T., Sui H., Zhang L. Exploring the Therapeutic Composition and Mechanism of Jiang-Suan-Chu-Bi Recipe on Gouty Arthritis Using an Integrated Approach Based on Chemical Profile, Network Pharmacology and Experimental Support Using Molecular Cell Biology. Front. Pharmacol. 2020;10:1626. doi: 10.3389/fphar.2019.01626.", "ArticleIdList": ["10.3389/fphar.2019.01626", "PMC7005212", "32082152"]}, {"Citation": "Shi Z., Li T., Liu Y., Cai T., Yao W., Jiang J., He Y., Shan L. Hepatoprotective and Anti-Oxidative Effects of Total Flavonoids From Qu Zhi Qiao (Fruit of Citrus Paradisi cv.Changshanhuyou) on Nonalcoholic Steatohepatitis In Vivo and In Vitro Through Nrf2-ARE Signaling Pathway. Front. Pharmacol. 2020;11:483. doi: 10.3389/fphar.2020.00483.", "ArticleIdList": ["10.3389/fphar.2020.00483", "PMC7189874", "32390839"]}, {"Citation": "Mu K., Wang D., Kitts D.D. Molecular Mechanisms That Define Redox Balance Function in Pathogen-Host Interactions-Is There a Role for Dietary Bioactive Polyphenols? Int. J. Mol. Sci. 2019;20:6222. doi: 10.3390/ijms20246222.", "ArticleIdList": ["10.3390/ijms20246222", "PMC6940965", "31835548"]}, {"Citation": "Baci D., Gallazzi M., Cascini C., Tramacere M., De Stefano D., Bruno A., Noonan D.M., Albini A. Downregulation of Pro-Inflammatory and Pro-Angiogenic Pathways in Prostate Cancer Cells by a Polyphenol-Rich Extract from Olive Mill Wastewater. Int. J. Mol. Sci. 2019;20:307. doi: 10.3390/ijms20020307.", "ArticleIdList": ["10.3390/ijms20020307", "PMC6359159", "30646518"]}, {"Citation": "Davis B.K., Wen H., Ting J.P. The Inflammasome NLRs in Immunity, Inflammation, and Associated Diseases. Annu. Rev. Immunol. 2011;29:707\u2013735. doi: 10.1146/annurev-immunol-031210-101405.", "ArticleIdList": ["10.1146/annurev-immunol-031210-101405", "PMC4067317", "21219188"]}, {"Citation": "Yang Y., Wang H., Kouadir M., Song H., Shi F. Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors. Cell Death Dis. 2019;10:128. doi: 10.1038/s41419-019-1413-8.", "ArticleIdList": ["10.1038/s41419-019-1413-8", "PMC6372664", "30755589"]}, {"Citation": "Bauernfeind F.G., Horvath G., Stutz A., Alnemri E.S., MacDonald K., Speert D., Fernandes-Alnemri T., Wu J., Monks B.G., Fitzgerald K.A., et al. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J. Immunol. 2009;183:787\u2013791. doi: 10.4049/jimmunol.0901363.", "ArticleIdList": ["10.4049/jimmunol.0901363", "PMC2824855", "19570822"]}, {"Citation": "Franchi L., Eigenbrod T., N\u00fa\u00f1ez G. Cutting edge: TNF-alpha mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation. J. Immunol. 2009;183:792\u2013796. doi: 10.4049/jimmunol.0900173.", "ArticleIdList": ["10.4049/jimmunol.0900173", "PMC2754237", "19542372"]}, {"Citation": "Owona B.A., Abia W.A., Moundipa P.F. Natural compounds flavonoids as modulators of inflammasomes in chronic diseases. Int. Immunopharmacol. 2020;84:106498. doi: 10.1016/j.intimp.2020.106498.", "ArticleIdList": ["10.1016/j.intimp.2020.106498", "32304996"]}, {"Citation": "Staurengo-Ferrari L., Ruiz-Miyazawa K.W., Pinho-Ribeiro F.A., Fattori V., Zaninelli T.H., Badaro-Garcia S., Borghi S.M., Carvalho T.T., Alves-Filho J.C., Cunha T.M., et al. Trans-Chalcone Attenuates Pain and Inflammation in Experimental Acute Gout Arthritis in Mice. Front. Pharmacol. 2018;9:1123. doi: 10.3389/fphar.2018.01123.", "ArticleIdList": ["10.3389/fphar.2018.01123", "PMC6176465", "30333752"]}, {"Citation": "Woo J., Cho S., Lee C.J. Isoliquiritigenin, a chalcone compound, enhances spontaneous inhibitory postsynaptic response. Exp. Neurobiol. 2014;23:163\u2013168. doi: 10.5607/en.2014.23.2.163.", "ArticleIdList": ["10.5607/en.2014.23.2.163", "PMC4065830", "24963281"]}, {"Citation": "Honda H., Nagai Y., Matsunaga T., Okamoto N., Watanabe Y., Tsuneyama K., Hayashi H., Fujii I., Ikutani M., Hirai Y., et al. Isoliquiritigenin is a potent inhibitor of NLRP3 inflammasome activation and diet-induced adipose tissue inflammation. J. Leukoc. Biol. 2014;96:1087\u20131100. doi: 10.1189/jlb.3A0114-005RR.", "ArticleIdList": ["10.1189/jlb.3A0114-005RR", "25210146"]}, {"Citation": "Kong X., Wu G., Chen S., Zhang L., Li F., Shao T., Ren L., Chen S.Y., Zhang H., McClain C.J., et al. Chalcone Derivative L6H21 Reduces EtOH + LPS-Induced Liver Injury Through Inhibition of NLRP3 Inflammasome Activation. Alcohol Clin. Exp. Res. 2019;43:1662\u20131671. doi: 10.1111/acer.14120.", "ArticleIdList": ["10.1111/acer.14120", "PMC6790986", "31162673"]}, {"Citation": "Lv H., Yang H., Wang Z., Feng H., Deng X., Cheng G., Ci X. Nrf2 signaling and autophagy are complementary in protecting lipopolysaccharide/d-galactosamine-induced acute liver injury by licochalcone A. Cell Death Dis. 2019;10:313. doi: 10.1038/s41419-019-1543-z.", "ArticleIdList": ["10.1038/s41419-019-1543-z", "PMC6450927", "30952839"]}, {"Citation": "Zhang Z., Li S., Cao H., Shen P., Liu J., Fu Y., Cao Y., Zhang N. The protective role of phloretin against dextran sulfate sodium-induced ulcerative colitis in mice. Food Funct. 2019;10:422\u2013431. doi: 10.1039/C8FO01699B.", "ArticleIdList": ["10.1039/C8FO01699B", "30604787"]}, {"Citation": "Yang G., Lee H.E., Yeon S.H., Kang H.C., Cho Y.Y., Lee H.S., Zouboulis C.C., Han S.H., Lee J.H., Lee J.Y. Licochalcone A attenuates acne symptoms mediated by suppression of NLRP3 inflammasome. Phytother. Res. 2018;32:2551\u20132559. doi: 10.1002/ptr.6195.", "ArticleIdList": ["10.1002/ptr.6195", "30281174"]}, {"Citation": "Tang Y.L., Zheng X., Qi Y., Pu X.J., Liu B., Zhang X., Li X.S., Xiao W.L., Wan C.P., Mao Z.W. Synthesis and anti-inflammatory evaluation of new chalcone derivatives bearing bispiperazine linker as IL-1\u03b2 inhibitors. Bioorg. Chem. 2020;98:103748. doi: 10.1016/j.bioorg.2020.103748.", "ArticleIdList": ["10.1016/j.bioorg.2020.103748", "32179281"]}, {"Citation": "He Y., Hara H., N\u00fa\u00f1ez G. Mechanism and Regulation of NLRP3 Inflammasome Activation. Trends Biochem. Sci. 2016;41:1012\u20131021. doi: 10.1016/j.tibs.2016.09.002.", "ArticleIdList": ["10.1016/j.tibs.2016.09.002", "PMC5123939", "27669650"]}, {"Citation": "Leu W.J., Chen J.C., Guh J.H. Extract from Plectranthus amboinicus Inhibit Maturation and Release of Interleukin 1\u03b2 Through Inhibition of NF-\u03baB Nuclear Translocation and NLRP3 Inflammasome Activation. Front. Pharmacol. 2019;10:573. doi: 10.3389/fphar.2019.00573.", "ArticleIdList": ["10.3389/fphar.2019.00573", "PMC6546882", "31191313"]}, {"Citation": "Liu T., Zhang L., Joo D., Sun S.C. NF-\u03baB signaling in inflammation. Signal Transduct. Target Ther. 2017;2:17023. doi: 10.1038/sigtrans.2017.23.", "ArticleIdList": ["10.1038/sigtrans.2017.23", "PMC5661633", "29158945"]}, {"Citation": "Brasier A.R. The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation. Cardiovasc. Res. 2010;86:211\u2013218. doi: 10.1093/cvr/cvq076.", "ArticleIdList": ["10.1093/cvr/cvq076", "PMC2912657", "20202975"]}, {"Citation": "Fann D.Y., Lim Y.A., Cheng Y.L., Lok K.Z., Chunduri P., Baik S.H., Drummond G.R., Dheen S.T., Sobey C.G., Jo D.G., et al. Evidence that NF-\u03baB and MAPK Signaling Promotes NLRP Inflammasome Activation in Neurons Following Ischemic Stroke. Mol. Neurobiol. 2018;55:1082\u20131096. doi: 10.1007/s12035-017-0394-9.", "ArticleIdList": ["10.1007/s12035-017-0394-9", "28092085"]}, {"Citation": "Schroder K., Zhou R., Tschopp J. The NLRP3 inflammasome: A sensor for metabolic danger? Science. 2010;327:296\u2013300. doi: 10.1126/science.1184003.", "ArticleIdList": ["10.1126/science.1184003", "20075245"]}, {"Citation": "Kelley N., Jeltema D., Duan Y., He Y. The NLRP3 Inflammasome: An overview of mechanisms of activation and Regulation. Int. J. Mol. Sci. 2019;20:3328. doi: 10.3390/ijms20133328.", "ArticleIdList": ["10.3390/ijms20133328", "PMC6651423", "31284572"]}, {"Citation": "Mu\u00f1oz-Planillo R., Kuffa P., Mart\u00ednez-Col\u00f3n G., Smith B.L., Rajendiran T.M., N\u00fa\u00f1ez G. K\u207a efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity. 2013;38:1142\u20131153. doi: 10.1016/j.immuni.2013.05.016.", "ArticleIdList": ["10.1016/j.immuni.2013.05.016", "PMC3730833", "23809161"]}, {"Citation": "Xue Y., Enosi Tuipulotu D., Tan W.H., Kay C., Man S.M. Emerging Activators and Regulators of Inflammasomes and Pyroptosis. Trends Immunol. 2019;40:1035\u20131052. doi: 10.1016/j.it.2019.09.005.", "ArticleIdList": ["10.1016/j.it.2019.09.005", "31662274"]}, {"Citation": "Marie J., Kovacs D., Pain C., Jouary T., Cota C., Vergier B., Picardo M., Taieb A., Ezzedine K., Cario-Andr\u00e9 M. Inflammasome activation and vitiligo/nonsegmental vitiligo progression. Br. J. Dermatol. 2014;170:816\u2013823. doi: 10.1111/bjd.12691.", "ArticleIdList": ["10.1111/bjd.12691", "24734946"]}, {"Citation": "Zhen Y., Zhang H. NLRP3 Inflammasome and Inflammatory Bowel Disease. Front. Immunol. 2019;10:276. doi: 10.3389/fimmu.2019.00276.", "ArticleIdList": ["10.3389/fimmu.2019.00276", "PMC6403142", "30873162"]}, {"Citation": "Pellegrini C., Fornai M., Antonioli L., Blandizzi C., Calderone V. Phytochemicals as novel therapeutic strategies for NLRP3 inflammasome-related neurological, metabolic, and inflammatory diseases. Int. J. Mol. Sci. 2019;20:2876. doi: 10.3390/ijms20122876.", "ArticleIdList": ["10.3390/ijms20122876", "PMC6627634", "31200447"]}, {"Citation": "Ma Q., Yang Q., Chen J., Yu C., Zhang L., Zhou W., Chen M. Salvianolic acid A ameliorates early-stage atherosclerosis development by inhibiting NLRP3 inflammasome activation in Zucker diabetic fatty rats. Molecules. 2020;25:1089. doi: 10.3390/molecules25051089.", "ArticleIdList": ["10.3390/molecules25051089", "PMC7179142", "32121151"]}, {"Citation": "Kawai T., Akira S. Signaling to NF-kappaB by Toll-like receptors. Trends Mol. Med. 2007;13:460\u2013469. doi: 10.1016/j.molmed.2007.09.002.", "ArticleIdList": ["10.1016/j.molmed.2007.09.002", "18029230"]}, {"Citation": "Song N., Liu Z.S., Xue W., Bai Z.F., Wang Q.Y., Dai J., Liu X., Huang Y.J., Cai H., Zhan X.Y., et al. NLRP3 phosphorylation is an essential priming event for inflammasome activation. Mol. Cell. 2017;68:185\u2013197. doi: 10.1016/j.molcel.2017.08.017.", "ArticleIdList": ["10.1016/j.molcel.2017.08.017", "28943315"]}, {"Citation": "Ghonime M.G., Shamaa O.R., Das S., Eldomany R.A., Fernandes-Alnemri T., Alnemri E.S., Gavrilin M.A., Wewers M.D. Inflammasome priming by lipopolysaccharide is dependent upon ERK signaling and proteasome function. J. Immunol. 2014;192:3881\u20133888. doi: 10.4049/jimmunol.1301974.", "ArticleIdList": ["10.4049/jimmunol.1301974", "PMC3980013", "24623131"]}, {"Citation": "Song N., Li T. Regulation of NLRP3 Inflammasome by Phosphorylation. Front. Immunol. 2018;9:2305. doi: 10.3389/fimmu.2018.02305.", "ArticleIdList": ["10.3389/fimmu.2018.02305", "PMC6186804", "30349539"]}, {"Citation": "Yeung Y.T., Aziz F., Guerrero-Castilla A., Arguelles S. Signaling pathways in inflammation and anti-inflammatory therapies. Curr. Pharm. Des. 2018;24:1449\u20131484. doi: 10.2174/1381612824666180327165604.", "ArticleIdList": ["10.2174/1381612824666180327165604", "29589535"]}, {"Citation": "Wang C., Hockerman S., Jacobsen E.J., Alippe Y., Selness S.R., Hope H.R., Hirsch J.L., Mnich S.J., Saabye M.J., Hood W.F., et al. Selective inhibition of the p38\u03b1 MAPK-MK2 axis inhibits inflammatory cues including inflammasome priming signals. J. Exp. Med. 2018;215:1315\u20131325. doi: 10.1084/jem.20172063.", "ArticleIdList": ["10.1084/jem.20172063", "PMC5940269", "29549113"]}, {"Citation": "Abais J.M., Xia M., Zhang Y., Boini K.M., Li P.L. Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector? Antioxid. Redox Signal. 2015;22:1111\u20131129. doi: 10.1089/ars.2014.5994.", "ArticleIdList": ["10.1089/ars.2014.5994", "PMC4403231", "25330206"]}, {"Citation": "Bauernfeind F., Bartok E., Rieger A., Franchi L., N\u00fa\u00f1ez G., Hornung V. Cutting edge: Reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome. J. Immunol. 2011;187:613\u2013617. doi: 10.4049/jimmunol.1100613.", "ArticleIdList": ["10.4049/jimmunol.1100613", "PMC3131480", "21677136"]}, {"Citation": "Van Bruggen R., K\u00f6ker M.Y., Jansen M., van Houdt M., Roos D., Kuijpers T.W., van den Berg T.K. Human NLRP3 inflammasome activation is Nox1-4 independent. Blood. 2010;115:5398\u20135400. doi: 10.1182/blood-2009-10-250803.", "ArticleIdList": ["10.1182/blood-2009-10-250803", "20407038"]}, {"Citation": "He Y., Zeng M.Y., Yang D., Motro B., N\u00fa\u00f1ez G. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature. 2016;530:354\u2013357. doi: 10.1038/nature16959.", "ArticleIdList": ["10.1038/nature16959", "PMC4810788", "26814970"]}, {"Citation": "Gro\u00df C.J., Mishra R., Schneider K.S., M\u00e9dard G., Wettmarshausen J., Dittlein D.C., Shi H., Gorka O., Koenig P.A., Fromm S., et al. K+efflux-independent NLRP3 inflammasome activation by small molecules targeting mitochondria. Immunity. 2016;45:761\u2013773. doi: 10.1016/j.immuni.2016.08.010.", "ArticleIdList": ["10.1016/j.immuni.2016.08.010", "27692612"]}, {"Citation": "Wang B., Tian Y., Yin Q. AIM2 Inflammasome Assembly and Signaling. Adv. Exp. Med. Biol. 2019;1172:143\u2013155.", "ArticleIdList": ["31628655"]}]}], "History": [{"Year": "2020", "Month": "10", "Day": "6"}, {"Year": "2020", "Month": "12", "Day": "11"}, {"Year": "2020", "Month": "12", "Day": "13"}, {"Year": "2020", "Month": "12", "Day": "19", "Hour": "1", "Minute": "2"}, {"Year": "2020", "Month": "12", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "9", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "12", "Day": "16"}], "PublicationStatus": "epublish", "ArticleIdList": ["33339319", "PMC7767297", "10.3390/molecules25245960", "molecules25245960"]}}]}